Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

UK Pharmacy

On this page you will find information for pharmacists involved in the RECOVERY Trial, including FAQs and HRA Pharmacy Assurance.

IMPORTANT NOTICES

September 2024: Baloxavir is available to order again from Roche. Please note that baloxavir packaging has changed and packs now contain 1x 40mg tablet. The pharmacy manual (V24.2) and ordering form (17-Sept-2024) have been updated to reflect this, but ordering procedures are otherwise unchanged. At present the maximum amount supplied to sites remains 10 packs due to supply limitations, but this will be increased before the winter flu season.

June 2024: Please note that current baloxavir supplied for RECOVERY has an expiry date of 30 June 2024. Replacement baloxavir can be ordered now from Roche, but deliveries of this will be delayed until the second half of July. This means that patients should not be randomised to the baloxavir comparison from 28 June until replacement baloxavir has been received.